1. PROTAC BET degraders are more broadly effective than BET inhibitors. (December 2016) Authors: Winkler, J.; Raina, K.; Altieri, M.; Dong, H.; Wang, J.; Chen, X.; Crew, A.; Crews, C.; Qian, Y.; Kleinfield, R.; Coleman, K. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗